Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Merit Medical Systems (MMSI) Capital Expenditures (2016 - 2025)

Historic Capital Expenditures for Merit Medical Systems (MMSI) over the last 16 years, with Q3 2025 value amounting to $22.4 million.

  • Merit Medical Systems' Capital Expenditures rose 13976.92% to $22.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $60.7 million, marking a year-over-year increase of 5647.69%. This contributed to the annual value of $35.1 million for FY2024, which is 247.89% up from last year.
  • Merit Medical Systems' Capital Expenditures amounted to $22.4 million in Q3 2025, which was up 13976.92% from $13.8 million recorded in Q2 2025.
  • In the past 5 years, Merit Medical Systems' Capital Expenditures ranged from a high of $22.4 million in Q3 2025 and a low of $3.5 million during Q4 2024
  • Its 5-year average for Capital Expenditures is $10.5 million, with a median of $9.4 million in 2024.
  • Per our database at Business Quant, Merit Medical Systems' Capital Expenditures tumbled by 5576.34% in 2021 and then surged by 13976.92% in 2025.
  • Merit Medical Systems' Capital Expenditures (Quarter) stood at $8.3 million in 2021, then surged by 49.99% to $12.5 million in 2022, then crashed by 42.84% to $7.1 million in 2023, then plummeted by 51.37% to $3.5 million in 2024, then skyrocketed by 546.31% to $22.4 million in 2025.
  • Its Capital Expenditures was $22.4 million in Q3 2025, compared to $13.8 million in Q2 2025 and $21.1 million in Q1 2025.